Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing

ABX464 is a first-in-class, clinical-stage, small molecule for oral administration that has shown strong anti-inflammatory effects in the DSS-model for inflammatory bowel disease (IBD) and also prevents replication of the HIV virus. ABX464 which binds to cap binding complex (CBC) has demonstrated sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vautrin, Audrey, Manchon, Laurent, Garcel, Aude, Campos, Noëlie, Lapasset, Laure, Laaref, Abdelhamid Mahdi, Bruno, Roman, Gislard, Marie, Dubois, Emeric, Scherrer, Didier, Ehrlich, J Hartmut, Tazi, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349857/
https://www.ncbi.nlm.nih.gov/pubmed/30692590
http://dx.doi.org/10.1038/s41598-018-37813-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349857/
https://www.ncbi.nlm.nih.gov/pubmed/30692590
http://dx.doi.org/10.1038/s41598-018-37813-y

Ejemplares similares